Previous 10 | Next 10 |
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that chief executive officer Shawn O’Connor will be presenting at the Sidoti Winter Small Cap Investor Conference taki...
Image source: The Motley Fool. SIMULATIONS PLUS, INC. (NASDAQ: SLP) Q1 2022 Earnings Call Jan 06, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: SIMULATIONS PLUS, INC. (SLP) Q1 2022 Earnings Call Transcript
Total revenue growth of 16%; Software revenue growth of 19%; Diluted Earnings Per Share (EPS) growth of 25% Board of Directors announces quarterly dividend of $0.06 per share Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation ...
Update includes enhanced PKanalix, Monolix, and Simulx modules Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its Lixoft division, a leading provider o...
Conference Call to be on Thursday, January 6, 2022, at 5:00 PM ET Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the first quarter of fiscal year 2022, the period ended November 30, 2021, after the close of the financial m...
Complementing the existing distributorship with ADMET Predictor® and GastroPlus® software Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it h...
Simulations Plus celebrates 25-year anniversary with $25,000 gift to nonprofit Dispensary of Hope Expanding access to high quality medication to people in need PR Newswire NASHVILLE, Tenn. , Nov. 30, 2021 /PRNewswire/ -- Simulations Plus (NASDAQ: SLP) is cele...
Expanding access to high-quality medication for people in need Simulations Plus, Inc. (Nasdaq: SLP) is celebrating 25 years in business and continuing the commitment to improve public health through innovative solutions with a $25,000 donation to the Dispensary of Hope...
Experienced Human Resource, Development and Organizational Leader Bolsters Board Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced ...
Yo-Yo dieting without additional treatment can explain high placebo response rates in NASH clinical trials Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced th...
News, Short Squeeze, Breakout and More Instantly...
Objective to define best practices for the use of novel PBK modeling strategies to support animal-free safety assessment of new chemicals Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance an...
Total revenue of $18.5 million and diluted earnings per share (EPS) of $0.15 Maintains full-year revenue guidance of $69 to $72 million and updates EPS guidance Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulati...
2024-06-24 16:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...